
    
      The 90% CI for pantoprazole ln(Cmax), ln[AUC(0-t)], and ln[AUC(0-inf)] for the comparison of
      the test product (pantoprazole) versus the reference product (Protonix) should be within the
      80 to 125% range required for the conclusion of bioequivalence.
    
  